Article Information
Published By
Online ISSN
History
- Received June 24, 2022
- Accepted October 18, 2022
- Published online November 17, 2022.
Article Versions
- You are currently viewing a previous version of this article (November 17, 2022 - 07:12).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Praveen Muralitharan1⇑,
- Petter Carlsen1,
- Magnus Hilland1,
- Irisz Delestre-Levai1,
- Maria Vollsæter1,2,
- Karl Ove Hufthammer3,
- Mette Engan1,
- Ola Drange Røksund2,4,
- Thomas Halvorsen1,2,5 and
- Hege H. Clemm1,2
- 1Department of Pediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway
- 2Department of Clinical Science, University of Bergen, Bergen, Norway
- 3Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway
- 4Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway
- 5Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway
- Corresponding author: Praveen Muralitharan (praveen.muralitharan{at}helse-bergen.no)
Funding
Medicines for Children Research Network, Norway
Article usage
Altmetrics
Vol 9 Issue 1
Table of Contents
Use of Inhaled ipratropium bromide to improve exercise induced laryngeal obstruction cannot be recommended
